


Summary
The regulation of similar biotherapeutic products varies widely among the different Latin American countries. While some of them are yet to introduce their own regulation, others — like Colombia, Brazil and Mexico — have opened ways to cheaper, complex and safe biological treatment for patients. However, many things need improving and a lot of experience is still necessary to develop a mature LATAM Biosimilars Market.
Biosimilars Latam – Colombia 2020 Forum is a unique and effective meeting point to share the information and experience Latin America’s Pharmaceutical Industry needs to develop a dynamic and thriving biosimilars market.
Join us in Colombia and trigger a quantum leap in Latin American Healthcare!
Who will
you meet?
More than:
Participants
Companies
HCPs
Patients
Academy
Investors
Institutions
Associations
Service Providers
Government Agencies
Industry Executives from Latam
From these areas:
- Biosimilars
- Biobetters
- Biotechnology
- Biotherapeutics
- Analytical science
- Regulatory compliance
- Quality Control
- Clinical immunology
- Scientific Affairs
- Pharmacovigilance
- Research
- Regulatory
- Business Development
- Marketing
Speaker Board

Juan Gayosso
Sartorius, Mexico
Business Development Manager Biosimilars
Business Development Manager Biosimilars

Juan Carlos Del Castillo
LifeFactors, Colombia
Partner
Partner

Miguel Angel Bustos
Cámara de Comercio de Bogotá, Colombia
Lider Cluster Farmacéutico
Lider Cluster Farmacéutico

Adriana Robayo
Institute for Health Technology Assessment - IETS (Colombian HTA Agency), Colombia
Executive Director
Executive Director

Jorge García Rojas
Bioredcol, Colombia
President
President

Nancy Huertas
Keralty, Colombia
Global Director of Pharmaceutical Affairs
Global Director of Pharmaceutical Affairs

Juan Pablo Osorio
Asociación Colombiana de Químicos Farmacéuticos Hospitalarios, Colombia
Presidente
Presidente

Claudia Marcela Betancour
Biointropic, Colombia
Executive Director
Executive Director

Carolina Gomez
Think Tank “Medicines, Information and Power” UNAL, Colombia
Founder and Researcher
Founder and Researcher

José Luis Méndez
ASINFAR, Colombia
Presidente Ejecutivo
Presidente Ejecutivo

Claudia Vaca
Think Tank “Medicines, Information and Power” UNAL, Colombia
Founder and Head
Founder and Head

Flavio Spegiorin Ramos
Kestener & Vieira Advogados, Brazil
Partner
Partner

Augusto Pich Otero
Laboratorio Pablo Cassará, Argentina
Gerente de Desarrollo Farmacéutico
Gerente de Desarrollo Farmacéutico

Nestor Perez
Probiomed, Mexico
COO and R&D Director
COO and R&D Director

Ignacio Gillmore
Carey / Universidad de Chile, Faculty of Chemistry & Pharmaceutical Sciences, Chile
Partner / Postgraduate Professor
Partner / Postgraduate Professor

Rodrigo Silvestre
Alfob, Brazil
Economist
Economist

María José Villarraza
Bioxentys, Argentina
CEO
CEO

Oscar Raziel Gamiz Vargas
Becton Dickinson, Mexico
Sr. Marketing Manager Pharmaceutical Systems LATAM
Sr. Marketing Manager Pharmaceutical Systems LATAM

Jose Josan
Universidad Peruana Cayetano Heredia, Peru
Professor
Professor

Sonia Mayra Pérez Tapia
UDIBI, Mexico
Executive Director
Executive Director

Paulo Etcheverry
Siegfried Laboratories, Colombia
Regional Manager
Regional Manager

Eduardo Cioppi
mAbxience, Spain
Global Sales Director
Global Sales Director

Joseph Cepeda
Colombia
Regulatory Affairs Specialist
Regulatory Affairs Specialist

Saul Guevara
Sartorius, Mexico
Product Manager
Product Manager
Perspectiva de los Biosimilares en Latam
Análisis de la Industria Biotecnológica Colombiana
Percepción de los Biosimilares por parte de Pacientes y Profesionales de la Salud Locales
Intercambiabilidad en Latam
Tecnología Actual Utilizada en Latam para el Desarrollo de Biosimilares
Estándar internacional para la evaluación y aprobación de productos biológicos / biosimilares
El Valor agregado que las organizaciones de pacientes le podemos brindar a la industria

Sponsors
Photo Gallery from Previous Events
